Windtree Therapeutics Inc
WINTDelisted- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946486
Windtree Therapeutics Inc was delisted in 2026; its insiders filed their last Form 4 on Oct 9, 2024; no institution reported holding it in 13F filings for Q2 2026; no superinvestor held it.
Holders of 5% or more of WINT
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Windtree Therapeutics Inc, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Windtree Therapeutics Inc on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
15 Schedule 13D and 13G filings on Windtree Therapeutics Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 14, 20254:44 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 2.55%288.6K shares | –Below 5% | Dec 31, 2024 | SEC |
| Nov 14, 2024 | Flynn James E | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Armistice Capital, LLC | 13GOld format | – | New | – | SEC |
| Nov 14, 2024 | Lind Global Fund II LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Lincoln Park Capital Fund, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Lind Global Fund II LP | 13G/AOld format | – | – | – | SEC |
| Feb 1, 2024 | Flynn James E | 13GOld format | – | New | – | SEC |
| Nov 13, 2023 | Duvvuri Krishna | 13GOld format | – | New | – | SEC |
| May 17, 2023 | Huang James | 13D/AOld format | – | – | – | SEC |
| Apr 28, 2023 | Lind Global Fund II LP | 13GOld format | – | New | – | SEC |
| Apr 24, 2023 | Lincoln Park Capital Fund, LLC | 13GOld format | – | New | – | SEC |
| Apr 19, 2023 | Huang James | 13D/AOld format | – | – | – | SEC |
| Feb 23, 2023 | Huang James | 13D/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Huang James | 13D/AOld format | – | – | – | SEC |
| Jan 10, 2022 | Center Laboratories, Inc. | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Windtree Therapeutics Inc shares.
No Form 144 notices for Windtree Therapeutics Inc are on file.